OptimizeRx (OPRX) SEC Filings & 10K Form

$10.81
-0.10 (-0.92%)
(As of 05/10/2024 ET)

Recent OptimizeRx SEC Filings

DateFilerForm TypeView
05/06/2024
8:32 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4/A
05/06/2024
8:34 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4/A
05/06/2024
8:35 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
7:35 AM
OptimizeRx (Filer)
Form DEF 14A
04/29/2024
7:38 AM
OptimizeRx (Filer)
Form ARS
04/22/2024
7:37 AM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4/A
04/22/2024
7:31 AM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4/A
04/18/2024
3:30 PM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2024
4:22 PM
FEBBO WILLIAM J (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
3:41 PM
OptimizeRx (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/28/2024
7:15 AM
OptimizeRx (Filer)
Form NT 10-K
03/06/2024
3:19 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:20 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
5:22 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
5:23 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
5:24 PM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
5:25 PM
Besch Doug (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
5:16 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
6:53 PM
KLEMA CATHY (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
4:04 PM
KLEMA CATHY (Reporting)
OptimizeRx (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/26/2024
3:00 PM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/18/2024
4:56 PM
FEBBO WILLIAM J (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
4:06 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:28 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/05/2024
4:19 PM
OptimizeRx (Filer)
Form 8-K/A
12/29/2023
4:30 PM
Divisadero Street Capital Management, LP (Filed by)
OptimizeRx (Subject)
Form SC 13G
11/13/2023
1:32 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2023
6:15 AM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2023
9:49 AM
Greco Theresa (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2023
3:06 PM
Greco Theresa (Reporting)
OptimizeRx (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/16/2023
3:31 PM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/12/2023
1:18 PM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
1:47 PM
Besch Doug (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
1:47 PM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
1:47 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
1:47 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
9:03 AM
HALAS GUS D (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
8:28 AM
OptimizeRx (Issuer)
WASSON GREGORY D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
8:29 AM
OptimizeRx (Issuer)
Vos Ellen O'Connor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
8:31 AM
Lang James Paul (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
8:33 AM
OptimizeRx (Issuer)
Spangler Patrick D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Tech GIANT’s Plans to Revolutionize Crypto… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.
08/14/2023
3:31 PM
OptimizeRx (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/09/2023
3:31 PM
First Light Asset Management, LLC (Filed by)
OptimizeRx (Subject)
Form SC 13G
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:OPRX) was last updated on 5/11/2024 by MarketBeat.com Staff

From Our Partners